Internal Medicine, Hematology & Oncology · Milwaukee, WI
NPI
1477516524
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
7
Medicare group memberships
Hospitals
5
Hospital affiliations
2900 W Oklahoma Ave
Milwaukee, WI, 53215
Phone (414) 649-6380
Groups this clinician bills Medicare through
Medicare paid, 2024
$89K
959 services
Medicare patients, 2024
202
Average age 72
Drug cost, 2024
$1.4M
1,028 prescriptions
Company payments, 2025
$221
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed N Haider was code 99233 (hospital e&m - subsequent), 441 times for 59 patients. In total Syed N Haider billed 959 services in 12 codes, and Medicare paid $89K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 441 | 59 | $86.51 | $38K |
| 99215 Office E&M - Established | Facility | 427 | 145 | $99.96 | $43K |
| 99223 Hospital E&M - Initial | Facility | 28 | 23 | $127.60 | $3,573 |
| 99214 Office E&M - Established | Facility | 16 | 15 | $67.33 | $1,077 |
| 99238 Hospital Discharge Management | Facility | 15 | 12 | $60.43 | $906 |
By year: 2022 $55K for 968 services; 2023 $47K for 522 services; 2024 $89K for 959 services.
Medicare prescription drug claims, 2024
In 2024, the drug Syed N Haider prescribed most often to Medicare patients was Acyclovir, with 150 prescriptions and refills. In total Syed N Haider wrote 1,028 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 150 | 209 | 41 | $1,507 |
| Valacyclovir Valacyclovir Hcl | 95 | 145 | 23 | $6,221 |
| Allopurinol Generic | 56 | 88 | 25 | $318 |
| Prednisone Generic | 44 | 47 | 22 | $134 |
| Levofloxacin Generic | 40 | 40 | 27 | $422 |
| Eliquis Apixaban | 38 | 40 | Under 11 | $22K |
| Pantoprazole Sodium Generic | 38 | 65 | 12 | $158 |
| Dexamethasone Generic | 35 | 35 | 15 | $359 |
| Potassium Chloride Generic | 32 | 38 | 11 | $278 |
| Loperamide Loperamide Hcl | 24 | 26 | Under 11 | $304 |
| Pomalyst Pomalidomide | 24 | 24 | Under 11 | $582K |
| Revlimid Lenalidomide | 24 | 24 | 12 | $401K |
| Montelukast Sodium Generic | 21 | 24 | 11 | $50.25 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 19 | 23 | Under 11 | $71.27 |
| Fluconazole Generic | 18 | 24 | 12 | $684 |
Brand drugs: 187 claims; generic drugs: 841 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed N Haider $221 ($221 in general payments such as food, travel and fees) from 3 companies. The largest payer was Janssen Biotech, Inc. with $136.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.